,reactionmeddraversionpt,reactionmeddrapt,safetyreportid,reactionoutcome
0,22.1,Blood count abnormal,17135433,
1,22.1,Therapy change,17135433,
0,22.1,Asthenia,17136367,
1,22.1,Fatigue,17136367,
2,22.1,Vomiting,17136367,
3,22.1,Depression,17136367,
4,22.1,Anxiety,17136367,
5,22.1,Decreased appetite,17136367,
6,22.1,Alopecia,17136367,
7,22.1,Restlessness,17136367,
8,22.1,Insomnia,17136367,
0,22.1,Neoplasm progression,17136436,
0,22.1,Death,17137563,
0,22.1,Coronary arterial stent insertion,17138158,
0,22.1,Somnolence,17138832,
0,22.1,Cough,17138978,
0,22.1,Off label use,17139338,
0,22.1,Therapy change,17140989,
1,22.1,Weight decreased,17140989,
0,22.1,Life support,17141009,
0,22.1,Vision blurred,17142629,
0,22.1,Death,17143314,
0,22.1,Disease progression,17143657,
0,22.1,Balance disorder,17144158,
0,22.1,Neutropenia,17145142,
1,22.1,Fatigue,17145142,
0,22.1,Vomiting,17145843,
0,22.1,Erythema,17145869,
1,22.1,Infusion related reaction,17145869,
2,22.1,Dry skin,17145869,
3,22.1,Decreased appetite,17145869,
4,22.1,Nausea,17145869,
0,22.1,Metastases to lung,17145882,
1,22.1,Thrombosis,17145882,
0,22.1,Dehydration,17146030,
0,22.1,Back pain,17146077,
1,22.1,Asthenia,17146077,
2,22.1,Energy increased,17146077,
3,22.1,Somnolence,17146077,
0,22.1,Drug ineffective,17146194,
0,22.1,Malaise,17146308,
1,22.1,Red blood cell count decreased,17146308,
0,22.1,Therapy cessation,17146378,
1,22.1,Constipation,17146378,
2,22.1,Hip surgery,17146378,
0,22.1,Death,17146430,
0,22.1,Colostomy,17149650,
0,22.1,Contusion,17149881,
1,22.1,Neck pain,17149881,
2,22.1,Fall,17149881,
0,22.1,Toxicity to various agents,17149962,
0,22.1,Diarrhoea,17150065,
1,22.1,Nausea,17150065,
2,22.1,Dizziness,17150065,
0,22.1,Diarrhoea,17150091,
1,22.1,Candida infection,17150091,
2,22.1,Bacterial toxaemia,17150091,
3,22.1,Vomiting,17150091,
0,22.1,Neutropenia,17150266,
0,22.1,Toxicity to various agents,17150426,
1,22.1,Pyrexia,17150426,
2,22.1,Cytopenia,17150426,
0,22.1,Death,17150529,
0,22.1,Erythema,17150769,
1,22.1,Skin disorder,17150769,
0,22.1,Disease progression,17150782,
0,22.1,Off label use,17151571,
0,22.1,Therapy cessation,17151913,
0,22.1,Death,17151929,
0,22.1,Death,17151991,
0,22.1,Dysuria,17152017,
1,22.1,Blood urine present,17152017,
0,22.1,Skin reaction,17152151,
0,22.1,Skin exfoliation,17156650,
1,22.1,Rash,17156650,
0,22.1,Death,17156691,
0,22.1,Peripheral swelling,17156715,
1,22.1,Diarrhoea,17156715,
0,22.1,Intentional product use issue,17156793,
0,22.1,Hyperventilation,17156830,
1,22.1,Cardiac failure congestive,17156830,
0,22.1,Disease progression,17156869,
1,22.1,Drug ineffective,17156869,
0,22.1,Nausea,17156989,
1,22.1,Weight decreased,17156989,
2,22.1,Dehydration,17156989,
0,22.1,Death,17157524,
0,22.1,Fatigue,17157887,
0,22.1,Bacteraemia,17157952,
0,22.1,Drug ineffective,17157977,
0,22.1,Fall,17158223,
1,22.1,Pneumonia,17158223,
0,22.1,Pneumonia,17158676,
0,22.1,Hot flush,17161355,
1,22.1,Cold sweat,17161355,
0,22.1,Therapy change,17162051,
1,22.1,Blood count abnormal,17162051,
0,22.1,Pneumonia,17163201,
0,22.1,Dry skin,17166957,
1,22.1,Psoriasis,17166957,
0,22.1,Death,17167050,
0,22.1,Death,17167506,
0,22.1,Musculoskeletal chest pain,17167938,
0,22.1,Malignant neoplasm progression,17168234,
0,22.1,Diarrhoea,17168840,
0,22.1,Death,17168958,
0,22.1,Nausea,17168984,
1,22.1,Dehydration,17168984,
0,22.1,Pneumonia,17169023,
1,22.1,Nervous system disorder,17169023,
0,22.1,Off label use,17169251,
0,22.1,Pyrexia,17171486,
1,22.1,Tachycardia,17171486,
2,22.1,Chills,17171486,
3,22.1,Confusional state,17171486,
4,22.1,Chest pain,17171486,
5,22.1,Tremor,17171486,
6,22.1,Wheezing,17171486,
7,22.1,Feeling cold,17171486,
8,22.1,Mental status changes,17171486,
9,22.1,Infusion related reaction,17171486,
0,22.1,Lymphoedema,17171740,
0,22.1,Intentional product use issue,17171908,
0,22.1,Vomiting,17172000,
1,22.1,Nausea,17172000,
0,22.1,Dyspepsia,17172677,
0,22.1,Rash erythematous,17172912,
1,22.1,Pruritus,17172912,
0,22.1,Angina bullosa haemorrhagica,17173120,
0,22.1,Neutropenia,17173129,
0,22.1,Sepsis,17173183,
1,22.1,Urinary tract infection,17173183,
0,22.1,Urinary tract infection,17173555,
0,22.1,Nausea,17174315,
1,22.1,Abdominal discomfort,17174315,
2,22.1,Blood glucose increased,17174315,
0,22.1,Disease progression,17182042,
0,22.1,Dyspnoea,17182693,
1,22.1,Therapy change,17182693,
2,22.1,Fatigue,17182693,
3,22.1,Heart rate increased,17182693,
4,22.1,Muscular weakness,17182693,
0,22.1,Localised infection,17183822,
1,22.1,Immunosuppression,17183822,
0,22.1,Neoplasm malignant,17184064,
0,22.1,Nausea,17184178,
1,22.1,Vomiting,17184178,
2,22.1,Diarrhoea,17184178,
3,22.1,Chills,17184178,
4,22.1,Dehydration,17184178,
0,22.1,Haematochezia,17184354,
1,22.1,Alopecia,17184354,
0,22.1,Diarrhoea,17184375,
1,22.1,Fatigue,17184375,
0,22.1,Gastric dilatation,17184385,
0,22.1,Death,17184671,
0,22.1,Rash,17184680,
1,22.1,Mouth swelling,17184680,
0,22.1,Surgery,17184703,
0,22.1,Abdominal discomfort,17184837,
0,22.1,Death,17185126,
0,22.1,Fatigue,17185582,
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,17185597,
0,22.1,Cystitis,17190550,
0,22.1,Myocardial infarction,17218220,
0,22.1,Fatigue,17095392,1
1,22.1,Colitis,17095392,1
2,22.1,Polyneuropathy,17095392,1
0,22.1,Radiation pneumonitis,17095517,6
1,22.1,Off label use,17095517,6
0,22.1,Off label use,17095518,6
1,22.1,Radiation pneumonitis,17095518,6
0,22.1,Radiation pneumonitis,17095521,6
0,22.1,Pneumonia,17095698,6
1,22.1,Neuropathy peripheral,17095698,3
0,22.1,Nausea,17095734,3
1,22.1,Tumour associated fever,17095734,3
2,22.1,Haemoglobin decreased,17095734,1
3,22.1,Fatigue,17095734,3
0,22.1,Thrombosis,17095756,1
1,22.1,Haemoptysis,17095756,6
2,22.1,Pruritus,17095756,6
3,22.1,Metastases to pelvis,17095756,3
4,22.1,Lower respiratory tract infection,17095756,3
5,22.1,Epistaxis,17095756,6
0,22.1,Blood pressure abnormal,17095784,6
1,22.1,Haemorrhage,17095784,1
2,22.1,Blood urine present,17095784,1
3,22.1,Vertigo,17095784,6
0,22.1,Rash pruritic,17095793,1
0,22.1,Weight increased,17095796,3
1,22.1,Bone pain,17095796,3
2,22.1,Oropharyngeal pain,17095796,3
3,22.1,Pruritus,17095796,3
4,22.1,Taste disorder,17095796,3
5,22.1,Neuropathy peripheral,17095796,3
6,22.1,Hypoaesthesia,17095796,3
7,22.1,Rhinorrhoea,17095796,3
8,22.1,Fatigue,17095796,3
0,22.1,Asthenia,17095826,6
1,22.1,Bone pain,17095826,6
2,22.1,Nausea,17095826,2
3,22.1,Hot flush,17095826,6
4,22.1,Vomiting,17095826,2
5,22.1,Swelling,17095826,6
6,22.1,Diarrhoea,17095826,6
0,22.1,Vertigo,17095836,1
0,22.1,Infusion related reaction,17095837,1
0,22.1,Prostatic specific antigen increased,17095844,6
0,22.1,Intentional product use issue,17095862,6
1,22.1,Diarrhoea,17095862,6
2,22.1,Bone marrow failure,17095862,6
3,22.1,Appendix cancer,17095862,5
4,22.1,Off label use,17095862,6
0,22.1,Tachypnoea,17095863,4
1,22.1,Malaise,17095863,4
2,22.1,Bronchospasm,17095863,4
3,22.1,Laryngospasm,17095863,4
0,22.1,Femur fracture,17095889,6
0,22.1,Malignant pleural effusion,17095897,1
1,22.1,Haemothorax,17095897,1
2,22.1,Pulmonary embolism,17095897,6
3,22.1,Neoplasm recurrence,17095897,6
0,22.1,Diarrhoea,17095917,6
1,22.1,Sepsis,17095917,6
2,22.1,Dehydration,17095917,1
0,22.1,Pancreatic disorder,17095952,6
1,22.1,Nephrolithiasis,17095952,1
2,22.1,Pneumonia,17095952,6
0,22.1,Platelet count decreased,17095967,2
1,22.1,Gastric ulcer haemorrhage,17095967,2
0,22.1,Death,17095969,5
1,22.1,Off label use,17095969,5
2,22.1,Intentional product use issue,17095969,5
0,22.1,Arteriospasm coronary,17095980,1
0,22.1,Weight decreased,17096013,1
1,22.1,Dyspnoea,17096013,1
2,22.1,Hypertension,17096013,1
3,22.1,Oxygen saturation decreased,17096013,1
0,22.1,Death,17096055,5
0,22.1,Disease progression,17096056,5
0,22.1,Anaphylactic shock,17096068,1
0,22.1,Ureteritis,17096072,6
0,22.1,Breast cancer metastatic,17096076,5
0,22.1,Haemothorax,17096119,2
1,22.1,Malignant neoplasm progression,17096119,2
2,22.1,Diarrhoea,17096119,6
3,22.1,Malignant pleural effusion,17096119,2
4,22.1,Metastases to pleura,17096119,6
5,22.1,Rash,17096119,6
0,22.1,Prostate cancer,17096155,5
0,22.1,Device related sepsis,17096211,1
0,22.1,Therapeutic product effect incomplete,17096226,6
1,22.1,Metastases to central nervous system,17096226,6
0,22.1,Fatigue,17096242,3
1,22.1,Back pain,17096242,3
2,22.1,Diarrhoea,17096242,3
3,22.1,Peripheral swelling,17096242,3
4,22.1,Rhinorrhoea,17096242,3
5,22.1,Hypoaesthesia,17096242,3
6,22.1,Neoplasm progression,17096242,3
0,22.1,Skin irritation,17096270,6
1,22.1,Ocular hyperaemia,17096270,6
2,22.1,Visual impairment,17096270,6
3,22.1,Retinal haemorrhage,17096270,6
4,22.1,Retinal detachment,17096270,6
0,22.1,Cardiac tamponade,17096322,6
0,22.1,Neuropathy peripheral,17096378,2
1,22.1,Anaphylactic shock,17096378,2
0,22.1,Disseminated intravascular coagulation,17096397,1
1,22.1,Thrombocytopenia,17096397,1
2,22.1,Neoplasm progression,17096397,6
0,22.1,Disease progression,17096407,6
0,22.1,Cholecystitis,17096409,1
0,22.1,Basal cell carcinoma,17096421,1
0,22.1,Neutropenia,17096433,6
0,22.1,Epistaxis,17096438,3
1,22.1,Abdominal pain,17096438,6
2,22.1,Nausea,17096438,6
3,22.1,Malaise,17096438,6
4,22.1,Diarrhoea,17096438,6
0,22.1,Blood creatine increased,17096439,3
1,22.1,Dehydration,17096439,3
0,22.1,Implant site pain,17096440,6
1,22.1,Metastases to meninges,17096440,2
2,22.1,Aphasia,17096440,2
3,22.1,Memory impairment,17096440,2
0,22.1,Diarrhoea,17096458,6
0,22.1,Haemothorax,17096459,1
1,22.1,Pulmonary embolism,17096459,6
2,22.1,Metastases to skin,17096459,6
3,22.1,Malignant pleural effusion,17096459,6
4,22.1,Malignant pleural effusion,17096459,1
5,22.1,Metastases to peritoneum,17096459,6
0,22.1,Vertigo,17096554,1
0,22.1,Malignant neoplasm progression,17096570,6
0,22.1,Neutropenia,17096612,1
1,22.1,Neoplasm progression,17096612,6
0,22.1,Transaminases increased,17096613,6
1,22.1,Food interaction,17096613,6
2,22.1,Depression,17096613,6
0,22.1,Weight decreased,17096694,1
1,22.1,Oxygen saturation decreased,17096694,1
2,22.1,Hypertension,17096694,1
3,22.1,Dyspnoea,17096694,1
0,22.1,Hypophagia,17096715,3
1,22.1,Laboratory test abnormal,17096715,3
2,22.1,Malaise,17096715,3
3,22.1,Thrombosis,17096715,3
0,22.1,Intestinal ischaemia,17096721,2
1,22.1,Dermatitis acneiform,17096721,1
2,22.1,Intestinal perforation,17096721,2
0,22.1,Fall,17096727,6
1,22.1,Cyst,17096727,6
0,22.1,Myelodysplastic syndrome,17096730,6
0,22.1,Rash erythematous,17096743,6
0,22.1,Febrile neutropenia,17096759,1
1,22.1,Platelet count decreased,17096759,2
0,22.1,Diabetes mellitus,17096762,6
1,22.1,Neoplasm malignant,17096762,6
0,22.1,Respiratory rate increased,17096777,1
1,22.1,Hypersensitivity,17096777,1
2,22.1,Chills,17096777,1
3,22.1,Hypotension,17096777,1
4,22.1,Tachycardia,17096777,1
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,17096801,1
0,22.1,Nodule,17096802,6
0,22.1,Anaemia,17096817,6
1,22.1,Nephropathy,17096817,6
2,22.1,Non-small cell lung cancer,17096817,6
0,22.1,Anaemia,17096922,1
1,22.1,Therapy cessation,17096922,6
0,22.1,Rash,17096928,1
0,22.1,Ill-defined disorder,17096929,6
1,22.1,Angina pectoris,17096929,6
0,22.1,Recurrent cancer,17096949,6
1,22.1,Disease progression,17096949,6
2,22.1,Drug ineffective,17096949,6
0,22.1,Malignant neoplasm progression,17096950,6
1,22.1,Pancytopenia,17096950,6
0,22.1,Recurrent cancer,17096959,6
1,22.1,Drug intolerance,17096959,6
2,22.1,Adverse drug reaction,17096959,6
3,22.1,Toxicity to various agents,17096959,6
4,22.1,Intentional product misuse,17096959,6
0,22.1,Recurrent cancer,17096962,6
1,22.1,Intentional product misuse,17096962,6
0,22.1,Recurrent cancer,17096964,6
0,22.1,Disease progression,17096965,6
1,22.1,Recurrent cancer,17096965,6
0,22.1,Bone marrow failure,17096966,6
0,22.1,Recurrent cancer,17096967,6
1,22.1,Toxicity to various agents,17096967,6
0,22.1,Recurrent cancer,17096969,6
0,22.1,Platelet count decreased,17097021,6
1,22.1,Malaise,17097021,6
2,22.1,Pruritus,17097021,6
3,22.1,Petechiae,17097021,6
4,22.1,Dizziness,17097021,6
5,22.1,Contusion,17097021,6
0,22.1,Platelet count decreased,17097023,1
1,22.1,Febrile neutropenia,17097023,1
2,22.1,Haemoglobin decreased,17097023,1
0,22.1,Neuropathy peripheral,17097065,6
1,22.1,Metastases to central nervous system,17097065,6
2,22.1,Radiation necrosis,17097065,6
0,22.1,Heart rate decreased,17097079,1
1,22.1,Loss of consciousness,17097079,1
2,22.1,Malaise,17097079,1
3,22.1,Retracted nipple,17097079,1
4,22.1,Hypotension,17097079,1
5,22.1,Hyperventilation,17097079,1
0,22.1,Malignant neoplasm progression,17097083,6
0,22.1,Psoriasis,17097100,1
0,22.1,Pulmonary oedema,17097134,2
1,22.1,Resuscitation,17097134,2
2,22.1,Hypoxia,17097134,2
3,22.1,Cardiomyopathy,17097134,2
0,22.1,Electrocardiogram repolarisation abnormality,17097165,3
0,22.1,Bone marrow failure,17097199,6
0,22.1,Malaise,17097225,6
1,22.1,Ovarian cancer metastatic,17097225,5
0,22.1,Confusional state,17097302,6
1,22.1,Drug ineffective,17097302,6
2,22.1,Myoclonus,17097302,6
0,22.1,Diabetes mellitus,17097311,6
0,22.1,Hypersensitivity,17097319,1
1,22.1,Liver disorder,17097319,1
0,22.1,Pulmonary haemorrhage,17097498,5
0,22.1,Pain,17097522,6
1,22.1,Sepsis,17097522,6
2,22.1,Vomiting,17097522,6
3,22.1,General physical health deterioration,17097522,6
4,22.1,Malaise,17097522,6
5,22.1,Asthenia,17097522,6
6,22.1,Diarrhoea,17097522,6
7,22.1,Pneumonia,17097522,6
8,22.1,Nausea,17097522,6
0,22.1,Pneumonia,17097530,2
0,22.1,Myelodysplastic syndrome,17097546,5
0,22.1,Death,17097558,5
0,22.1,Malignant neoplasm progression,17097670,6
0,22.1,Carbohydrate antigen 125 increased,17097672,3
0,22.1,Bone marrow failure,17097700,1
0,22.1,Cytopenia,17097704,6
1,22.1,Diarrhoea,17097704,6
2,22.1,Gastrointestinal disorder,17097704,6
0,22.1,Systemic lupus erythematosus,17097706,3
0,22.1,Extradural haematoma,17097722,4
1,22.1,Fall,17097722,4
0,22.1,Drug interaction,17097749,5
1,22.1,Thrombocytosis,17097749,5
2,22.1,Anaemia,17097749,5
3,22.1,Death,17097749,5
4,22.1,Chronic myeloid leukaemia,17097749,5
5,22.1,Polyneuropathy,17097749,5
0,22.1,Neoplasm progression,17097822,6
1,22.1,Death,17097822,5
0,22.1,Death,17097823,5
0,22.1,Haemorrhage intracranial,17097838,5
1,22.1,Cerebral haemorrhage,17097838,5
2,22.1,Hypomagnesaemia,17097838,3
0,22.1,Acute lymphocytic leukaemia,17097877,5
0,22.1,Blood creatinine increased,17097884,2
0,22.1,Death,17097887,5
0,22.1,Death,17097888,5
0,22.1,Hypermagnesaemia,17097900,1
1,22.1,Hypomagnesaemia,17097900,1
0,22.1,Electrocardiogram QT prolonged,17097919,6
1,22.1,Vitiligo,17097919,6
0,22.1,Premature delivery,17097921,6
1,22.1,Maternal exposure during pregnancy,17097921,6
2,22.1,Foetal hypokinesia,17097921,6
3,22.1,Product use in unapproved indication,17097921,6
0,22.1,Dermatitis exfoliative,17097938,4
1,22.1,Skin exfoliation,17097938,2
2,22.1,Cough,17097938,6
3,22.1,Skin irritation,17097938,2
4,22.1,Swelling,17097938,2
0,22.1,Thrombocytopenia,17097946,6
1,22.1,Product use in unapproved indication,17097946,6
0,22.1,Polyneuropathy,17097982,6
1,22.1,Pruritus,17097982,6
2,22.1,Gastrointestinal disorder,17097982,6
3,22.1,Dacryostenosis acquired,17097982,6
4,22.1,Hot flush,17097982,6
0,22.1,Constipation,17098035,3
1,22.1,Balance disorder,17098035,3
2,22.1,Headache,17098035,3
3,22.1,Irritability,17098035,3
4,22.1,Stomatitis,17098035,3
5,22.1,Fatigue,17098035,3
6,22.1,Interstitial lung disease,17098035,3
0,22.1,Death,17098069,5
1,22.1,Vomiting,17098069,2
2,22.1,Pain in extremity,17098069,2
3,22.1,Haemoglobin decreased,17098069,2
4,22.1,Pruritus,17098069,6
5,22.1,General physical health deterioration,17098069,2
6,22.1,Haemorrhage,17098069,1
7,22.1,Disease recurrence,17098069,2
8,22.1,Dizziness,17098069,2
9,22.1,Fatigue,17098069,2
10,22.1,Dehydration,17098069,2
11,22.1,Dyspnoea,17098069,2
12,22.1,Neoplasm progression,17098069,6
13,22.1,Asthenia,17098069,2
14,22.1,Nausea,17098069,2
15,22.1,Iron deficiency anaemia,17098069,2
16,22.1,Red blood cell count decreased,17098069,1
17,22.1,Rash,17098069,6
0,22.1,Neutropenia,17098073,1
1,22.1,Cardio-respiratory arrest,17098073,5
2,22.1,Anaemia,17098073,3
3,22.1,Thrombocytopenia,17098073,1
0,22.1,Febrile neutropenia,17098079,1
0,22.1,Limb discomfort,17098086,3
1,22.1,Myalgia,17098086,3
2,22.1,Nail disorder,17098086,3
3,22.1,Pneumonia,17098086,3
4,22.1,Blood phosphorus decreased,17098086,3
5,22.1,Musculoskeletal chest pain,17098086,3
6,22.1,Upper respiratory tract infection,17098086,3
7,22.1,Viral infection,17098086,3
8,22.1,Lymphoedema,17098086,3
9,22.1,Blood cholesterol increased,17098086,3
10,22.1,Blood potassium decreased,17098086,3
11,22.1,Musculoskeletal pain,17098086,3
12,22.1,Neck pain,17098086,3
13,22.1,Urinary tract infection,17098086,3
14,22.1,Lymphadenopathy,17098086,3
15,22.1,Mucosal inflammation,17098086,3
16,22.1,Stomatitis,17098086,3
17,22.1,Anaemia,17098086,3
18,22.1,Back pain,17098086,3
19,22.1,Diarrhoea,17098086,3
20,22.1,Pain in extremity,17098086,3
0,22.1,Asthma,17098090,2
1,22.1,Paraesthesia,17098090,2
2,22.1,Skin exfoliation,17098090,2
3,22.1,Chest pain,17098090,2
4,22.1,Nail disorder,17098090,2
5,22.1,Nausea,17098090,2
6,22.1,Diarrhoea,17098090,2
7,22.1,Heart rate irregular,17098090,2
8,22.1,Rash,17098090,2
9,22.1,Vomiting,17098090,2
10,22.1,Neoplasm progression,17098090,2
11,22.1,Drug hypersensitivity,17098090,2
12,22.1,Neuropathy peripheral,17098090,2
13,22.1,Device related thrombosis,17098090,2
0,22.1,Dysphonia,17098094,1
1,22.1,Hypoacusis,17098094,3
2,22.1,Rhinitis,17098094,1
3,22.1,Hypertension,17098094,3
4,22.1,Anxiety,17098094,1
0,22.1,Dyspepsia,17098097,6
1,22.1,Pain,17098097,6
2,22.1,Spinal disorder,17098097,6
3,22.1,Fatigue,17098097,6
0,22.1,Cardiac tamponade,17098112,6
0,22.1,Lower respiratory tract infection,17098157,1
1,22.1,Pneumonia,17098157,1
0,22.1,Neutropenic sepsis,17098166,1
0,22.1,Pneumonia,17098170,1
0,22.1,Mucosal disorder,17098187,1
1,22.1,White blood cell count decreased,17098187,1
2,22.1,Pyrexia,17098187,1
0,22.1,Pruritus,17098188,1
0,22.1,Dysgeusia,17098190,3
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,17098190,3
2,22.1,Hypertension,17098190,3
3,22.1,Rash,17098190,3
4,22.1,Diarrhoea,17098190,3
5,22.1,Anaemia,17098190,3
6,22.1,Fatigue,17098190,3
7,22.1,Neutropenia,17098190,3
8,22.1,Decreased appetite,17098190,3
9,22.1,Mucosal inflammation,17098190,3
10,22.1,Nausea,17098190,3
11,22.1,Gastrooesophageal reflux disease,17098190,3
12,22.1,Thrombocytopenia,17098190,3
0,22.1,Dehydration,17098192,1
1,22.1,Diarrhoea,17098192,1
2,22.1,Dyspnoea,17098192,6
3,22.1,Atrial fibrillation,17098192,1
4,22.1,Arrhythmia,17098192,6
5,22.1,Skin lesion,17098192,1
0,22.1,Lung disorder,17098213,2
0,22.1,Fatigue,17098270,6
0,22.1,Localised infection,17098279,6
0,22.1,Neoplasm progression,17098283,6
1,22.1,Sinusitis,17098283,6
2,22.1,Platelet count decreased,17098283,6
3,22.1,Depression,17098283,6
0,22.1,Pancytopenia,17098292,6
0,22.1,Diabetic ketoacidotic hyperglycaemic coma,17098324,6
1,22.1,Thrombocytopenia,17098324,6
2,22.1,Diabetes mellitus,17098324,6
3,22.1,Acute kidney injury,17098324,6
0,22.1,Interstitial lung disease,17098351,1
1,22.1,Off label use,17098351,6
2,22.1,Malignant neoplasm progression,17098351,6
3,22.1,Lymphangiosis carcinomatosa,17098351,6
0,22.1,White blood cell count decreased,17098405,2
1,22.1,Myalgia,17098405,1
2,22.1,Renal impairment,17098405,6
3,22.1,Confusional state,17098405,6
4,22.1,Neutrophil count decreased,17098405,6
5,22.1,Influenza like illness,17098405,1
6,22.1,Diarrhoea,17098405,1
7,22.1,Constipation,17098405,1
8,22.1,Fatigue,17098405,6
9,22.1,Vomiting,17098405,1
10,22.1,Memory impairment,17098405,6
0,22.1,Influenza,17098408,2
0,22.1,Cognitive disorder,17098427,3
1,22.1,Loss of personal independence in daily activities,17098427,6
2,22.1,Back disorder,17098427,6
0,22.1,Pneumonitis,17098472,6
1,22.1,Pneumonia aspiration,17098472,2
0,22.1,Gastrointestinal disorder,17098485,2
0,22.1,Cerebrovascular accident,17098499,6
1,22.1,Neoplasm progression,17098499,6
0,22.1,White blood cell count decreased,17098520,2
1,22.1,Musculoskeletal pain,17098520,3
2,22.1,Blood magnesium decreased,17098520,6
3,22.1,Nasopharyngitis,17098520,6
4,22.1,Underdose,17098520,6
5,22.1,Platelet count decreased,17098520,2
6,22.1,Nausea,17098520,3
0,22.1,Neurotoxicity,17098531,6
1,22.1,Anaemia,17098531,6
2,22.1,Hypertension,17098531,6
0,22.1,Off label use,17098620,6
1,22.1,Product use in unapproved indication,17098620,6
2,22.1,Neoplasm progression,17098620,5
0,22.1,Neoplasm progression,17098637,6
0,22.1,Dizziness,17098644,6
1,22.1,Panic attack,17098644,6
2,22.1,Cardiac failure,17098644,3
3,22.1,Extrasystoles,17098644,6
4,22.1,Anxiety,17098644,6
5,22.1,Palpitations,17098644,6
0,22.1,Sepsis,17098647,5
0,22.1,Malaise,17098648,6
1,22.1,Bone marrow failure,17098648,6
0,22.1,Bone marrow failure,17098649,6
1,22.1,White blood cell count decreased,17098649,6
0,22.1,Tremor,17098656,1
0,22.1,White blood cell count decreased,17098696,6
0,22.1,Device related infection,17098713,1
1,22.1,Systemic bacterial infection,17098713,1
2,22.1,Asthenia,17098713,6
3,22.1,Weight decreased,17098713,6
0,22.1,Tonsillar disorder,17098721,6
1,22.1,Lower limb fracture,17098721,6
2,22.1,Nasal disorder,17098721,6
0,22.1,Blood creatine increased,17098722,3
1,22.1,Dehydration,17098722,3
0,22.1,Blood triglycerides increased,17098771,2
1,22.1,Hypocalcaemia,17098771,2
0,22.1,Cough,17098806,6
1,22.1,Nasal congestion,17098806,6
0,22.1,Bone disorder,17098823,6
0,22.1,Confusional state,17098825,6
0,22.1,Stomatitis,17098833,6
1,22.1,Sinusitis,17098833,1
2,22.1,Blood pressure abnormal,17098833,1
0,22.1,Nausea,17098834,6
1,22.1,Fatigue,17098834,6
2,22.1,Depressed mood,17098834,6
0,22.1,Asthenia,17098847,6
0,22.1,Neoplasm progression,17098859,6
0,22.1,Rash papular,17098861,2
0,22.1,Lung disorder,17098957,6
1,22.1,Cardiac tamponade,17098957,6
0,22.1,Product use in unapproved indication,17099005,6
1,22.1,Neuropathy peripheral,17099005,6
2,22.1,Palmar-plantar erythrodysaesthesia syndrome,17099005,2
3,22.1,Thrombocytopenia,17099005,6
0,22.1,Neutropenia,17099026,6
0,22.1,Haemoptysis,17099062,1
0,22.1,Neoplasm,17099073,6
0,22.1,Recurrent cancer,17099100,6
1,22.1,Disease progression,17099100,6
0,22.1,Thyroid cancer metastatic,17099113,
1,22.1,Thyroid cancer,17099113,3
0,22.1,Pulmonary toxicity,17099117,1
1,22.1,Fulminant type 1 diabetes mellitus,17099117,6
2,22.1,Diabetic ketoacidosis,17099117,1
0,22.1,Haematemesis,17099136,5
1,22.1,Thrombocytopenia,17099136,5
0,22.1,Small intestinal obstruction,17099145,6
1,22.1,Product use complaint,17099145,6
2,22.1,Musculoskeletal stiffness,17099145,6
3,22.1,Product size issue,17099145,6
0,22.1,Dermatosis,17099166,1
1,22.1,Wound dehiscence,17099166,2
2,22.1,Infection,17099166,3
0,22.1,Neoplasm progression,17099247,6
0,22.1,Respiratory failure,17099249,6
1,22.1,Death,17099249,5
2,22.1,Interstitial lung disease,17099249,6
3,22.1,Vomiting,17099249,6
4,22.1,Anxiety,17099249,6
5,22.1,Coronary artery disease,17099249,6
6,22.1,Spinal osteoarthritis,17099249,6
7,22.1,Oral candidiasis,17099249,6
8,22.1,Nausea,17099249,6
9,22.1,Hiatus hernia,17099249,6
10,22.1,Synovial cyst,17099249,6
11,22.1,Pneumonitis,17099249,6
12,22.1,Pulmonary embolism,17099249,6
13,22.1,Lymphadenopathy,17099249,6
14,22.1,Osteoporosis,17099249,6
0,22.1,Renal function test abnormal,17099272,6
1,22.1,Acne,17099272,6
2,22.1,Blister,17099272,6
3,22.1,Liver function test increased,17099272,6
0,22.1,Adverse event,17099281,6
0,22.1,Neoplasm progression,17099283,6
0,22.1,Product dose omission,17099284,6
1,22.1,Nausea,17099284,1
0,22.1,Neoplasm progression,17099288,6
0,22.1,Neoplasm progression,17099295,6
0,22.1,White blood cell count decreased,17099296,6
0,22.1,Off label use,17099328,6
0,22.1,Death,17099335,
0,22.1,Nail disorder,17099383,6
1,22.1,Alopecia,17099383,3
2,22.1,Neutrophil count decreased,17099383,6
3,22.1,Pain of skin,17099383,6
4,22.1,Nail ridging,17099383,6
0,22.1,Pancreatitis,17099388,6
1,22.1,Nausea,17099388,1
2,22.1,Abdominal pain upper,17099388,6
3,22.1,Leukopenia,17099388,1
4,22.1,Gingival swelling,17099388,6
5,22.1,Dyspepsia,17099388,6
6,22.1,Diarrhoea,17099388,1
7,22.1,Thermal burn,17099388,6
8,22.1,Gingival pain,17099388,6
9,22.1,Weight decreased,17099388,2
10,22.1,Ageusia,17099388,1
0,22.1,Upper respiratory tract infection,17099409,6
1,22.1,Full blood count decreased,17099409,6
0,22.1,Recurrent cancer,17099427,6
1,22.1,Disease progression,17099427,6
2,22.1,Drug ineffective,17099427,6
0,22.1,Recurrent cancer,17099430,6
1,22.1,Drug ineffective,17099430,6
2,22.1,Intentional product misuse,17099430,6
3,22.1,Disease progression,17099430,6
0,22.1,Incorrect dose administered,17099445,6
1,22.1,Mental disorder,17099445,6
0,22.1,Alopecia,17099466,6
0,22.1,Hair colour changes,17099469,3
1,22.1,Alopecia,17099469,3
2,22.1,Hair texture abnormal,17099469,3
3,22.1,Hair disorder,17099469,3
0,22.1,Madarosis,17099473,3
1,22.1,Hair disorder,17099473,3
2,22.1,Hair colour changes,17099473,3
3,22.1,Alopecia,17099473,3
4,22.1,Hair texture abnormal,17099473,3
0,22.1,Alopecia,17099499,3
1,22.1,Neoplasm progression,17099499,6
0,22.1,White blood cell count decreased,17099511,6
0,22.1,Alopecia,17099514,3
1,22.1,Hair texture abnormal,17099514,3
2,22.1,Hair colour changes,17099514,3
3,22.1,Hair disorder,17099514,3
4,22.1,Madarosis,17099514,3
0,22.1,Body height decreased,17099516,6
1,22.1,Intervertebral disc compression,17099516,6
2,22.1,Nervousness,17099516,6
3,22.1,Gait disturbance,17099516,2
4,22.1,Spinal stenosis,17099516,2
0,22.1,Madarosis,17099521,3
1,22.1,Hair colour changes,17099521,3
2,22.1,Hair texture abnormal,17099521,3
3,22.1,Hair disorder,17099521,3
4,22.1,Alopecia,17099521,3
0,22.1,Hair texture abnormal,17099527,3
1,22.1,Alopecia,17099527,3
2,22.1,Hair colour changes,17099527,3
3,22.1,Depression,17099527,6
4,22.1,Madarosis,17099527,3
5,22.1,Hair disorder,17099527,3
0,22.1,Alopecia,17099529,3
1,22.1,Hair colour changes,17099529,6
2,22.1,Madarosis,17099529,3
3,22.1,Depression,17099529,6
4,22.1,Hair disorder,17099529,6
5,22.1,Hair texture abnormal,17099529,6
0,22.1,Neoplasm progression,17099536,6
1,22.1,White blood cell count decreased,17099536,1
0,22.1,Hair texture abnormal,17099540,1
1,22.1,Alopecia,17099540,1
2,22.1,Hair disorder,17099540,1
3,22.1,Hair colour changes,17099540,1
4,22.1,Madarosis,17099540,1
0,22.1,Hair disorder,17099543,3
1,22.1,Hair colour changes,17099543,3
2,22.1,Madarosis,17099543,3
3,22.1,Alopecia,17099543,3
4,22.1,Hair texture abnormal,17099543,3
0,22.1,Hair disorder,17099544,3
1,22.1,Depression,17099544,6
2,22.1,Alopecia,17099544,3
3,22.1,Hair texture abnormal,17099544,3
4,22.1,Hair colour changes,17099544,3
5,22.1,Madarosis,17099544,3
0,22.1,Hair colour changes,17099549,3
1,22.1,Hair disorder,17099549,3
2,22.1,Alopecia,17099549,3
3,22.1,Hair texture abnormal,17099549,3
4,22.1,Madarosis,17099549,3
0,22.1,Heart rate increased,17099557,1
1,22.1,Diarrhoea,17099557,1
2,22.1,Urinary tract infection,17099557,1
3,22.1,Cough,17099557,1
4,22.1,Dysuria,17099557,1
5,22.1,Oral candidiasis,17099557,1
6,22.1,Mucosal inflammation,17099557,1
7,22.1,Neutropenic infection,17099557,1
8,22.1,Blood pressure increased,17099557,1
0,22.1,Fatigue,17099580,6
1,22.1,Hypertension,17099580,6
2,22.1,Neurotoxicity,17099580,6
3,22.1,Anaemia,17099580,6
4,22.1,Thrombocytopenia,17099580,6
5,22.1,Asthenia,17099580,6
6,22.1,Neutropenia,17099580,6
0,22.1,Enterocolitis,17099585,2
0,22.1,Device related infection,17099604,1
1,22.1,Systemic bacterial infection,17099604,1
0,22.1,Nausea,17099613,1
1,22.1,Diarrhoea,17099613,1
0,22.1,Neutropenia,17099623,1
1,22.1,Metastases to lymph nodes,17099623,6
0,22.1,Pleural effusion,17099626,4
0,22.1,Palpitations,17099674,1
1,22.1,Arrhythmia,17099674,1
2,22.1,Drug interaction,17099674,1
3,22.1,Supraventricular extrasystoles,17099674,1
4,22.1,Feeling abnormal,17099674,1
5,22.1,Loss of consciousness,17099674,1
6,22.1,Muscle spasms,17099674,1
7,22.1,Dizziness,17099674,1
8,22.1,Aphasia,17099674,1
9,22.1,Nausea,17099674,1
10,22.1,Neurological symptom,17099674,1
0,22.1,Neutropenia,17099700,6
0,22.1,Hypoglycaemia,17099702,6
1,22.1,Drug interaction,17099702,6
0,22.1,Thrombosis,17099709,1
1,22.1,Product use issue,17099709,3
2,22.1,Laboratory test abnormal,17099709,3
0,22.1,Platelet toxicity,17099770,
1,22.1,Metastases to peritoneum,17099770,
2,22.1,Portal hypertension,17099770,
3,22.1,Metastases to lung,17099770,
0,22.1,Hair colour changes,17099778,3
1,22.1,Alopecia,17099778,3
2,22.1,Hair disorder,17099778,3
3,22.1,Madarosis,17099778,3
4,22.1,Hair texture abnormal,17099778,3
0,22.1,Alopecia,17099781,3
0,22.1,Madarosis,17099783,3
1,22.1,Hair colour changes,17099783,3
2,22.1,Hair disorder,17099783,3
3,22.1,Alopecia,17099783,3
4,22.1,Hair texture abnormal,17099783,3
0,22.1,Panic attack,17099784,6
1,22.1,Hair disorder,17099784,3
2,22.1,Madarosis,17099784,3
3,22.1,Hair texture abnormal,17099784,3
4,22.1,Depression,17099784,6
5,22.1,Alopecia,17099784,3
6,22.1,Anxiety,17099784,6
7,22.1,Hair colour changes,17099784,3
0,22.1,Ventricular dysfunction,17099868,3
0,22.1,Hair disorder,17099874,3
1,22.1,Madarosis,17099874,3
2,22.1,Alopecia,17099874,3
3,22.1,Hair texture abnormal,17099874,3
4,22.1,Hair colour changes,17099874,3
0,22.1,Alopecia,17099935,3
1,22.1,Hair colour changes,17099935,3
2,22.1,Madarosis,17099935,3
3,22.1,Hair texture abnormal,17099935,3
4,22.1,Hair disorder,17099935,3
0,22.1,Decreased appetite,17099954,2
1,22.1,Aspartate aminotransferase increased,17099954,3
2,22.1,Hepatic enzyme increased,17099954,3
3,22.1,Decubitus ulcer,17099954,2
4,22.1,Inappropriate schedule of product administration,17099954,6
5,22.1,Alanine aminotransferase increased,17099954,3
0,22.1,Neutropenia,17099956,2
1,22.1,Leukopenia,17099956,2
2,22.1,Inappropriate schedule of product administration,17099956,6
3,22.1,Rash,17099956,3
0,22.1,Cerebrovascular accident,17100026,2
0,22.1,Recurrent cancer,17100039,6
1,22.1,Drug ineffective,17100039,6
2,22.1,Disease progression,17100039,6
0,22.1,Recurrent cancer,17100040,6
1,22.1,Intentional product misuse,17100040,6
0,22.1,Thrombocytopenia,17100093,6
1,22.1,Herpes simplex,17100093,1
2,22.1,Epistaxis,17100093,1
3,22.1,Rash,17100093,1
4,22.1,Pain,17100093,6
5,22.1,Thrombocytopenia,17100093,1
6,22.1,Neuropathy peripheral,17100093,3
7,22.1,Anaemia,17100093,1
8,22.1,Nausea,17100093,1
9,22.1,Product use in unapproved indication,17100093,6
10,22.1,Dermatitis acneiform,17100093,1
11,22.1,Hypertrichosis,17100093,1
0,22.1,Death,17100104,5
0,22.1,Prostate cancer metastatic,17100107,6
1,22.1,Prostatic specific antigen increased,17100107,3
2,22.1,Injection site pain,17100107,1
0,22.1,Premature menopause,17100113,1
0,22.1,Injection site mass,17100121,6
1,22.1,Injection site infection,17100121,6
2,22.1,Weight decreased,17100121,6
3,22.1,Injection site pain,17100121,6
0,22.1,Angioedema,17100130,1
0,22.1,Allergic cough,17100182,1
0,22.1,Death,17100184,5
0,22.1,Oral disorder,17100224,6
1,22.1,Food refusal,17100224,6
2,22.1,Pain in jaw,17100224,6
3,22.1,Oral pain,17100224,6
4,22.1,Hypoaesthesia,17100224,6
5,22.1,Off label use,17100224,
6,22.1,Terminal state,17100224,3
7,22.1,Mouth swelling,17100224,6
8,22.1,Colon cancer,17100224,3
9,22.1,Adverse drug reaction,17100224,6
0,22.1,Mastitis,17100248,6
0,22.1,Death,17100277,5
0,22.1,Death,17100286,5
1,22.1,Off label use,17100286,6
0,22.1,Myeloproliferative neoplasm,17100335,6
0,22.1,Therapeutic product effect decreased,17100343,3
0,22.1,Adverse drug reaction,17100360,3
0,22.1,Pancytopenia,17100362,3
1,22.1,Overdose,17100362,3
2,22.1,Acute kidney injury,17100362,3
0,22.1,Ejection fraction decreased,17100368,3
1,22.1,Cardiac failure,17100368,3
0,22.1,General physical health deterioration,17100385,6
1,22.1,Death,17100385,5
0,22.1,Off label use,17100400,
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,17100400,3
2,22.1,Pain,17100400,3
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,17100401,1
1,22.1,Colon cancer,17100401,3
0,22.1,Feeling hot,17100409,1
1,22.1,Drug hypersensitivity,17100409,1
2,22.1,Flushing,17100409,1
3,22.1,Dyspnoea,17100409,1
4,22.1,Chest pain,17100409,1
0,22.1,Acute kidney injury,17100418,2
1,22.1,Hypokalaemia,17100418,1
2,22.1,Thrombocytopenia,17100418,3
3,22.1,Dysphagia,17100418,3
4,22.1,Mucosal inflammation,17100418,3
5,22.1,Agranulocytosis,17100418,1
0,22.1,Hypokalaemia,17100424,1
1,22.1,General physical health deterioration,17100424,4
2,22.1,Diarrhoea,17100424,1
0,22.1,Agitation,17100425,1
1,22.1,Tremor,17100425,1
2,22.1,Oxygen saturation decreased,17100425,1
3,22.1,Hypotension,17100425,1
0,22.1,Product dose omission,17100444,6
1,22.1,Off label use,17100444,6
0,22.1,Musculoskeletal chest pain,17100501,6
0,22.1,Subcutaneous abscess,17100559,1
1,22.1,Infection,17100559,1
2,22.1,Impaired healing,17100559,3
3,22.1,Vein disorder,17100559,1
4,22.1,Arthralgia,17100559,4
0,22.1,Therapeutic product effect decreased,17100581,6
1,22.1,Prostatic specific antigen increased,17100581,6
0,22.1,Prostate cancer,17100598,3
1,22.1,Weight increased,17100598,6
0,22.1,Therapeutic product effect decreased,17100602,6
1,22.1,Death,17100602,5
0,22.1,Emotional distress,17100776,6
1,22.1,Psychological trauma,17100776,6
2,22.1,Impaired quality of life,17100776,6
3,22.1,Alopecia,17100776,3
4,22.1,Anxiety,17100776,6
5,22.1,Pain,17100776,6
0,22.1,Alopecia,17100787,3
0,22.1,Psychological trauma,17100788,6
1,22.1,Alopecia,17100788,2
0,22.1,Alopecia,17100789,2
0,22.1,Alopecia,17100790,2
1,22.1,Psychological trauma,17100790,6
0,22.1,Psychological trauma,17100793,6
1,22.1,Anxiety,17100793,6
2,22.1,Impaired quality of life,17100793,6
3,22.1,Pain,17100793,6
4,22.1,Alopecia,17100793,3
5,22.1,Emotional distress,17100793,6
0,22.1,Alopecia,17100794,2
1,22.1,Pain,17100794,6
2,22.1,Psychological trauma,17100794,6
3,22.1,Anxiety,17100794,6
4,22.1,Emotional distress,17100794,6
5,22.1,Impaired quality of life,17100794,6
0,22.1,Neuropathy peripheral,17100801,3
1,22.1,Pain,17100801,3
2,22.1,Mobility decreased,17100801,3
0,22.1,Psychological trauma,17100893,6
1,22.1,Alopecia,17100893,2
0,22.1,Psychological trauma,17100894,6
1,22.1,Alopecia,17100894,2
0,22.1,Alopecia,17100898,2
0,22.1,Alopecia,17100910,2
0,22.1,Alopecia,17100915,2
0,22.1,Psychological trauma,17100916,6
1,22.1,Anxiety,17100916,6
2,22.1,Pain,17100916,6
3,22.1,Emotional distress,17100916,6
4,22.1,Impaired quality of life,17100916,6
5,22.1,Alopecia,17100916,3
0,22.1,Death,17100969,5
0,22.1,Alopecia,17100977,2
1,22.1,Psychological trauma,17100977,6
2,22.1,Anxiety,17100977,6
3,22.1,Pain,17100977,6
4,22.1,Emotional distress,17100977,6
5,22.1,Impaired quality of life,17100977,6
0,22.1,Fatigue,17101053,3
1,22.1,Thrombosis,17101053,2
2,22.1,Malaise,17101053,2
3,22.1,Hypertension,17101053,2
4,22.1,Asthenia,17101053,3
5,22.1,Dyspnoea exertional,17101053,3
0,22.1,Alopecia,17101057,2
0,22.1,Neuropathy peripheral,17101058,3
1,22.1,Insomnia,17101058,3
2,22.1,Nausea,17101058,6
3,22.1,Cerebral disorder,17101058,6
4,22.1,Headache,17101058,3
5,22.1,Spondylitis,17101058,6
6,22.1,Balance disorder,17101058,6
7,22.1,Vomiting,17101058,6
8,22.1,Tremor,17101058,2
9,22.1,Pain in extremity,17101058,6
10,22.1,Dyspepsia,17101058,6
11,22.1,Dizziness,17101058,3
12,22.1,Fall,17101058,6
13,22.1,Blood pressure increased,17101058,3
0,22.1,Disease progression,17101059,6
1,22.1,Recurrent cancer,17101059,6
0,22.1,Recurrent cancer,17101060,6
1,22.1,Bone marrow toxicity,17101060,6
2,22.1,Drug ineffective,17101060,6
3,22.1,Disease progression,17101060,6
0,22.1,Alopecia,17101062,2
0,22.1,Psychological trauma,17101068,6
1,22.1,Alopecia,17101068,2
0,22.1,Psychological trauma,17101072,6
1,22.1,Pain,17101072,6
2,22.1,Anxiety,17101072,6
3,22.1,Alopecia,17101072,2
4,22.1,Emotional distress,17101072,6
5,22.1,Impaired quality of life,17101072,6
0,22.1,Alopecia,17101075,2
0,22.1,Alopecia,17101085,3
1,22.1,Emotional distress,17101085,6
2,22.1,Impaired quality of life,17101085,6
3,22.1,Anxiety,17101085,6
4,22.1,Psychological trauma,17101085,6
5,22.1,Pain,17101085,6
0,22.1,Alopecia,17101087,3
1,22.1,Impaired quality of life,17101087,6
2,22.1,Emotional distress,17101087,6
3,22.1,Pain,17101087,6
4,22.1,Psychological trauma,17101087,6
5,22.1,Anxiety,17101087,6
0,22.1,Alopecia,17101090,2
1,22.1,Psychological trauma,17101090,6
0,22.1,Alopecia,17101094,2
1,22.1,Psychological trauma,17101094,6
0,22.1,Pain,17101097,6
1,22.1,Psychological trauma,17101097,6
2,22.1,Alopecia,17101097,2
3,22.1,Impaired quality of life,17101097,6
4,22.1,Emotional distress,17101097,6
5,22.1,Anxiety,17101097,6
0,22.1,Alopecia,17101100,2
0,22.1,Alopecia,17101104,2
0,22.1,Pain,17101107,6
1,22.1,Emotional distress,17101107,6
2,22.1,Impaired quality of life,17101107,6
3,22.1,Anxiety,17101107,6
4,22.1,Psychological trauma,17101107,6
5,22.1,Alopecia,17101107,2
0,22.1,Psychological trauma,17101109,6
1,22.1,Alopecia,17101109,2
0,22.1,Alopecia,17101112,2
0,22.1,Aura,17101148,3
1,22.1,Lacrimation increased,17101148,3
2,22.1,Muscular weakness,17101148,3
3,22.1,Pruritus,17101148,3
4,22.1,Dysgeusia,17101148,3
5,22.1,Malaise,17101148,3
6,22.1,Memory impairment,17101148,3
7,22.1,Thinking abnormal,17101148,3
8,22.1,Toothache,17101148,3
9,22.1,Urogenital prolapse,17101148,3
10,22.1,Abdominal discomfort,17101148,3
11,22.1,Mean platelet volume decreased,17101148,3
12,22.1,Diarrhoea,17101148,3
13,22.1,Dyspnoea exertional,17101148,3
14,22.1,Laryngitis,17101148,3
15,22.1,Palpitations,17101148,3
16,22.1,Blood pressure increased,17101148,3
17,22.1,Vomiting,17101148,3
18,22.1,Depression,17101148,3
19,22.1,Hypotension,17101148,3
20,22.1,Influenza,17101148,3
21,22.1,Oxygen saturation decreased,17101148,3
22,22.1,Stomatitis,17101148,3
23,22.1,Speech disorder,17101148,3
24,22.1,Tooth infection,17101148,3
25,22.1,Uterine prolapse,17101148,3
0,22.1,Anaemia,17101228,1
1,22.1,Hyponatraemia,17101228,1
2,22.1,Pancytopenia,17101228,1
0,22.1,Alopecia,17101243,2
0,22.1,Alopecia,17101244,2
0,22.1,Alopecia,17101248,2
0,22.1,Psychological trauma,17101255,6
1,22.1,Alopecia,17101255,3
0,22.1,Alopecia,17101262,2
0,22.1,Alopecia,17101267,2
1,22.1,Psychological trauma,17101267,6
0,22.1,Alopecia,17101290,2
0,22.1,Psychological trauma,17101294,6
1,22.1,Alopecia,17101294,2
0,22.1,Alopecia,17101307,3
0,22.1,Alopecia,17101311,2
0,22.1,Alopecia,17101312,2
0,22.1,Alopecia,17101314,3
0,22.1,Alopecia,17101316,2
1,22.1,Psychological trauma,17101316,6
0,22.1,Alopecia,17101332,3
1,22.1,Psychological trauma,17101332,6
0,22.1,Non-small cell lung cancer metastatic,17101429,6
0,22.1,Lung abscess,17101526,6
1,22.1,Interstitial lung disease,17101526,6
0,22.1,Neuropathy peripheral,17101544,2
0,22.1,Vomiting,17101546,1
1,22.1,Nausea,17101546,1
2,22.1,Diarrhoea,17101546,1
0,22.1,Pneumonia,17101557,1
1,22.1,Ileus,17101557,1
0,22.1,Oedema peripheral,17101576,1
0,22.1,Ageusia,17101599,6
1,22.1,Anosmia,17101599,6
2,22.1,Arthralgia,17101599,2
3,22.1,Fatigue,17101599,2
4,22.1,Carbohydrate antigen 125 increased,17101599,6
5,22.1,Anxiety,17101599,2
6,22.1,Headache,17101599,2
7,22.1,Blood pressure increased,17101599,6
8,22.1,Arthritis,17101599,2
9,22.1,Dyssomnia,17101599,2
0,22.1,White blood cell count decreased,17101608,1
1,22.1,Immune-mediated nephritis,17101608,1
2,22.1,Anaemia,17101608,2
3,22.1,Platelet count decreased,17101608,6
0,22.1,Bone marrow failure,17101633,2
0,22.1,Chest pain,17101647,2
1,22.1,Haematemesis,17101647,1
2,22.1,Stoma site haemorrhage,17101647,1
3,22.1,Ulcer,17101647,2
0,22.1,Arthralgia,17101660,6
1,22.1,Mouth ulceration,17101660,6
2,22.1,Pleural effusion,17101660,6
0,22.1,Drug ineffective,17101661,6
1,22.1,Disease progression,17101661,6
2,22.1,Recurrent cancer,17101661,6
3,22.1,Intentional product misuse,17101661,6
0,22.1,Blood glucose increased,17101662,6
1,22.1,Mean cell volume increased,17101662,6
2,22.1,Hypertension,17101662,1
3,22.1,Blood creatinine decreased,17101662,6
4,22.1,Dry skin,17101662,3
5,22.1,White blood cell count decreased,17101662,6
6,22.1,Haemoglobin decreased,17101662,6
7,22.1,Lymphocyte count decreased,17101662,6
8,22.1,Hypothyroidism,17101662,6
9,22.1,Blood urea increased,17101662,6
10,22.1,Red blood cell count decreased,17101662,6
0,22.1,Disease progression,17101663,6
1,22.1,Vomiting,17101663,6
2,22.1,Recurrent cancer,17101663,6
0,22.1,Recurrent cancer,17101664,6
1,22.1,Disease progression,17101664,6
2,22.1,Drug ineffective,17101664,6
0,22.1,Recurrent cancer,17101665,6
1,22.1,Disease progression,17101665,6
0,22.1,Hospitalisation,17101666,6
1,22.1,Product dose omission,17101666,6
0,22.1,Thrombocytopenia,17101667,1
1,22.1,Myalgia,17101667,3
2,22.1,Limb discomfort,17101667,3
3,22.1,Fatigue,17101667,3
4,22.1,Constipation,17101667,2
5,22.1,Herpes zoster,17101667,3
6,22.1,Decreased appetite,17101667,1
7,22.1,Nasopharyngitis,17101667,3
8,22.1,Arthralgia,17101667,3
9,22.1,Blood pressure increased,17101667,3
10,22.1,Carbohydrate antigen 125 increased,17101667,3
11,22.1,Product dose omission,17101667,6
12,22.1,Intentional dose omission,17101667,6
13,22.1,Recurrent cancer,17101667,6
14,22.1,Pyrexia,17101667,6
15,22.1,Neuralgia,17101667,3
16,22.1,Therapy cessation,17101667,6
17,22.1,Tachycardia,17101667,1
18,22.1,Emotional distress,17101667,6
19,22.1,Paraesthesia,17101667,3
20,22.1,Nausea,17101667,1
21,22.1,Cough,17101667,3
22,22.1,Therapeutic response unexpected,17101667,3
23,22.1,Off label use,17101667,3
24,22.1,Nasal congestion,17101667,3
25,22.1,Peripheral swelling,17101667,3
26,22.1,Cataract,17101667,3
27,22.1,Scratch,17101667,3
28,22.1,Pain in extremity,17101667,3
29,22.1,Urinary tract infection,17101667,3
30,22.1,Diarrhoea,17101667,6
0,22.1,Extremity necrosis,17101689,2
1,22.1,Antiphospholipid syndrome,17101689,6
2,22.1,Peripheral artery thrombosis,17101689,6
0,22.1,Hospitalisation,17101728,6
0,22.1,Thrombocytopenia,17101729,6
1,22.1,Recurrent cancer,17101729,6
2,22.1,Disease progression,17101729,6
0,22.1,Insulin autoimmune syndrome,17101763,6
0,22.1,Pneumonia viral,17101764,3
1,22.1,Dermatomyositis,17101764,3
0,22.1,Pneumonia aspiration,17101773,1
1,22.1,Small intestinal perforation,17101773,1
2,22.1,Peritonitis,17101773,1
3,22.1,Small intestine ulcer,17101773,1
4,22.1,Pulmonary embolism,17101773,1
5,22.1,Malignant neoplasm progression,17101773,1
0,22.1,Unevaluable event,17101832,
1,22.1,Headache,17101832,
2,22.1,Hospitalisation,17101832,6
3,22.1,Feeling abnormal,17101832,3
4,22.1,Alopecia,17101832,6
0,22.1,Hypersensitivity,17101864,1
0,22.1,Face oedema,17101899,1
1,22.1,Erythema,17101899,1
2,22.1,Abdominal pain,17101899,1
3,22.1,Nausea,17101899,1
0,22.1,Hypertension,17101942,6
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,17101942,6
2,22.1,Neuropathy peripheral,17101942,3
3,22.1,Incorrect dose administered,17101942,
4,22.1,Skin burning sensation,17101942,3
5,22.1,Blood pressure increased,17101942,2
0,22.1,Cholestasis,17101959,1
0,22.1,Colorectal cancer,17101962,5
1,22.1,Skin fissures,17101962,1
0,22.1,Fatigue,17101967,
1,22.1,Fatigue,17101967,3
2,22.1,Dry skin,17101967,
3,22.1,Diarrhoea,17101967,
4,22.1,Oropharyngeal pain,17101967,
5,22.1,Embolism,17101967,
6,22.1,Toxicity to various agents,17101967,3
7,22.1,Dry skin,17101967,3
8,22.1,Vomiting,17101967,3
0,22.1,Rash papular,17101979,3
1,22.1,Weight increased,17101979,6
2,22.1,Pyrexia,17101979,1
3,22.1,Myocardial infarction,17101979,5
0,22.1,Epistaxis,17101990,6
1,22.1,Neurotoxicity,17101990,6
2,22.1,Neutropenia,17101990,6
3,22.1,Asthenia,17101990,6
4,22.1,Alopecia,17101990,6
5,22.1,Nausea,17101990,6
6,22.1,Rhinitis,17101990,6
7,22.1,Diarrhoea,17101990,6
0,22.1,Renal impairment,17102039,6
0,22.1,Ejection fraction decreased,17102094,1
0,22.1,Cerebral haemorrhage,17102102,5
0,22.1,Pneumonia,17102136,1
1,22.1,Dyspnoea,17102136,2
2,22.1,Fatigue,17102136,6
3,22.1,Feeling cold,17102136,1
4,22.1,Chills,17102136,1
5,22.1,Pyrexia,17102136,1
6,22.1,Pain,17102136,2
7,22.1,Eructation,17102136,6
8,22.1,Hypersensitivity,17102136,6
9,22.1,Dizziness,17102136,6
0,22.1,Malignant neoplasm progression,17102181,6
1,22.1,Metastatic squamous cell carcinoma,17102181,6
0,22.1,Cardiotoxicity,17102207,6
0,22.1,Inappropriate schedule of product administration,17102289,6
1,22.1,Lower limb fracture,17102289,6
2,22.1,Pulmonary embolism,17102289,6
0,22.1,Recurrent cancer,17102328,6
1,22.1,Toxicity to various agents,17102328,6
2,22.1,Drug ineffective,17102328,6
3,22.1,Drug intolerance,17102328,6
0,22.1,Recurrent cancer,17102329,6
1,22.1,Drug intolerance,17102329,6
2,22.1,Toxicity to various agents,17102329,6
0,22.1,Recurrent cancer,17102330,6
1,22.1,Disease progression,17102330,6
0,22.1,Disease progression,17102331,6
1,22.1,Recurrent cancer,17102331,6
2,22.1,Drug ineffective,17102331,6
0,22.1,Acne,17102341,6
1,22.1,Product dose omission,17102341,6
2,22.1,Product use in unapproved indication,17102341,6
3,22.1,Rash,17102341,6
0,22.1,Product use in unapproved indication,17102374,6
1,22.1,Abdominal discomfort,17102374,6
0,22.1,Cholestasis,17102380,5
1,22.1,Hepatocellular injury,17102380,5
0,22.1,Platelet count decreased,17102403,6
1,22.1,Product use in unapproved indication,17102403,6
2,22.1,Rash,17102403,6
3,22.1,Disease progression,17102403,6
4,22.1,Weight decreased,17102403,6
0,22.1,K-ras gene mutation,17102470,6
1,22.1,Therapy non-responder,17102470,6
2,22.1,Skin toxicity,17102470,6
3,22.1,PIK3CA-activated mutation,17102470,6
4,22.1,PTEN gene mutation,17102470,6
0,22.1,Language disorder,17102493,2
1,22.1,Arthralgia,17102493,6
2,22.1,Metastases to bone,17102493,6
3,22.1,Cerebral artery stenosis,17102493,6
4,22.1,Hemiparesis,17102493,1
5,22.1,Cerebral infarction,17102493,2
6,22.1,Metastases to lung,17102493,6
7,22.1,Breast cancer recurrent,17102493,6
8,22.1,Malignant neoplasm progression,17102493,6
0,22.1,Thrombocytopenia,17102494,1
1,22.1,Anaemia,17102494,1
2,22.1,Melaena,17102494,1
3,22.1,Mucosal haemorrhage,17102494,1
0,22.1,Uterine cancer,17102540,5
0,22.1,Ovarian cancer,17102557,5
0,22.1,Nausea,17102625,6
1,22.1,Vision blurred,17102625,6
2,22.1,Visual impairment,17102625,6
0,22.1,Cardiac arrest,17102662,5
0,22.1,Myocardial infarction,17102688,6
0,22.1,Hydronephrosis,17102699,6
1,22.1,Cough,17102699,6
2,22.1,Metastatic carcinoma of the bladder,17102699,5
3,22.1,Transitional cell carcinoma metastatic,17102699,6
4,22.1,Metastases to bone,17102699,6
5,22.1,Asthenia,17102699,6
6,22.1,Dyspnoea,17102699,6
0,22.1,Pneumonia,17102739,2
0,22.1,Rash,17102749,1
1,22.1,Rotavirus infection,17102749,1
2,22.1,Cardiac valve sclerosis,17102749,2
3,22.1,Mitral valve incompetence,17102749,2
4,22.1,Sinus arrhythmia,17102749,6
5,22.1,Tricuspid valve incompetence,17102749,2
6,22.1,Diastolic dysfunction,17102749,1
7,22.1,Atrial fibrillation,17102749,1
8,22.1,Tachycardia,17102749,1
9,22.1,Supraventricular tachyarrhythmia,17102749,6
10,22.1,Diarrhoea,17102749,1
11,22.1,Vomiting,17102749,1
12,22.1,Nausea,17102749,1
13,22.1,Pyrexia,17102749,1
14,22.1,Hypertensive crisis,17102749,3
15,22.1,Atrioventricular block first degree,17102749,6
0,22.1,Malaise,17102750,6
1,22.1,Nausea,17102750,6
2,22.1,Abdominal discomfort,17102750,6
3,22.1,Decreased appetite,17102750,6
0,22.1,Acute respiratory distress syndrome,17102780,2
1,22.1,Azotaemia,17102780,5
2,22.1,Deep vein thrombosis,17102780,6
3,22.1,Multiple organ dysfunction syndrome,17102780,5
4,22.1,Sepsis,17102780,5
5,22.1,Postoperative ileus,17102780,1
6,22.1,Renal impairment,17102780,2
0,22.1,Death,17102781,5
1,22.1,Off label use,17102781,5
0,22.1,Off label use,17102796,6
1,22.1,Thrombocytopenia,17102796,2
2,22.1,Bone marrow failure,17102796,6
3,22.1,Intentional product use issue,17102796,6
4,22.1,White blood cell count decreased,17102796,1
0,22.1,Device leakage,17102821,6
1,22.1,Neutrophil count decreased,17102821,2
0,22.1,Ascites,17102826,1
0,22.1,Decreased appetite,17102831,3
1,22.1,Insomnia,17102831,6
0,22.1,Portal hypertension,17102859,6
1,22.1,Varices oesophageal,17102859,6
0,22.1,Death,17102891,
0,22.1,Adrenal disorder,17102893,1
0,22.1,Off label use,17102942,6
1,22.1,Pulmonary fibrosis,17102942,6
0,22.1,Pulmonary embolism,17102971,5
1,22.1,Disease progression,17102971,5
0,22.1,Peripheral ischaemia,17102982,1
0,22.1,Colitis,17102983,6
1,22.1,Death,17102983,5
0,22.1,Psoriasis,17102990,6
1,22.1,Peripheral swelling,17102990,6
2,22.1,Metastases to lung,17102990,6
3,22.1,Joint swelling,17102990,6
4,22.1,Off label use,17102990,6
0,22.1,Diarrhoea,17103005,
1,22.1,Dizziness,17103005,
2,22.1,Syncope,17103005,
3,22.1,Dark circles under eyes,17103005,
4,22.1,Gastroenteritis Escherichia coli,17103005,
5,22.1,Skin discolouration,17103005,
6,22.1,Gait inability,17103005,
0,22.1,Rash,17103032,1
0,22.1,Death,17103062,5
1,22.1,Pneumonitis,17103062,6
0,22.1,Fulminant type 1 diabetes mellitus,17103085,3
1,22.1,Hypothyroidism,17103085,3
2,22.1,Blood corticotrophin decreased,17103085,3
3,22.1,Hyperthyroidism,17103085,3
4,22.1,Adrenal insufficiency,17103085,3
0,22.1,Encephalopathy,17103094,1
1,22.1,Febrile neutropenia,17103094,1
0,22.1,Neutrophil count decreased,17103138,3
1,22.1,Diarrhoea,17103138,2
2,22.1,Alopecia,17103138,6
3,22.1,Fatigue,17103138,3
4,22.1,White blood cell count decreased,17103138,3
5,22.1,Vomiting,17103138,6
6,22.1,Nausea,17103138,6
0,22.1,Hypoalbuminaemia,17103141,2
0,22.1,Large intestinal stenosis,17103158,1
1,22.1,Diarrhoea,17103158,1
2,22.1,Condition aggravated,17103158,1
3,22.1,Decreased appetite,17103158,6
0,22.1,Vomiting,17103163,6
1,22.1,Oesophagitis,17103163,2
2,22.1,Product use in unapproved indication,17103163,6
3,22.1,Gastritis,17103163,1
4,22.1,Myalgia,17103163,6
5,22.1,Fatigue,17103163,6
6,22.1,Abdominal pain,17103163,6
7,22.1,Pyrexia,17103163,6
8,22.1,Diarrhoea,17103163,6
9,22.1,Nausea,17103163,6
0,22.1,Malaise,17103179,
1,22.1,Therapy cessation,17103179,
0,22.1,Intentional product use issue,17103202,6
1,22.1,Metastases to ovary,17103202,6
2,22.1,Mechanical ileus,17103202,6
3,22.1,Off label use,17103202,6
0,22.1,Hyperglycaemia,17103206,1
1,22.1,Embolic stroke,17103206,4
0,22.1,Bone marrow failure,17103213,2
1,22.1,Vomiting,17103213,2
2,22.1,Decreased appetite,17103213,2
3,22.1,Nausea,17103213,2
4,22.1,Asthenia,17103213,2
0,22.1,Product use in unapproved indication,17103241,6
0,22.1,Hypothalamo-pituitary disorder,17103260,3
1,22.1,Malignant neoplasm progression,17103260,5
0,22.1,Platelet count decreased,17103266,1
0,22.1,Gait inability,17103306,
1,22.1,Spinal disorder,17103306,
2,22.1,Neoplasm,17103306,
0,22.1,Pericardial effusion,17103310,2
1,22.1,Pain,17103310,3
0,22.1,Pleural effusion,17103316,
0,22.1,Hot flush,17103351,
